Cite
van der Veer A, van der Velden VH, Willemse ME, et al. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood Cancer J. 2014;4:e181doi: 10.1038/bcj.2014.5.
van der Veer, A., van der Velden, V. H., Willemse, M. E., Hoogeveen, P. G., Petricoin, E. F., Beverloo, H. B., Escherich, G., Horstmann, M. A., Pieters, R., & den Boer, M. L. (2014). Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood cancer journal, 4e181. https://doi.org/10.1038/bcj.2014.5
van der Veer, A, et al. "Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia." Blood cancer journal vol. 4 (2014): e181. doi: https://doi.org/10.1038/bcj.2014.5
van der Veer A, van der Velden VH, Willemse ME, Hoogeveen PG, Petricoin EF, Beverloo HB, Escherich G, Horstmann MA, Pieters R, den Boer ML. Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia. Blood Cancer J. 2014 Feb 14;4:e181. doi: 10.1038/bcj.2014.5. PMID: 24531445; PMCID: PMC3944663.
Copy
Download .nbib